Unaudited Condensed Consolidated Statement of Cash Flows	3 Months Ended	6 Months Ended
	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Cash flows from operating activities:
Net loss	$ (25,100,000)	$ (33,034,000)	$ (46,361,000)
Adjustments to reconcile net loss to net cash used in operations:
Share-based compensation		17,326,000	16,210,000
Depreciation and amortization		3,597,000	3,536,000
Amortization of right-of-use assets		1,305,000	1,579,000
Allowance for doubtful accounts		216,000	171,000
Impairment of right-of-use assets	0	186,000	0
Loss on impairment of long lived assets		0	536,000
Change in fair value of warrant liabilities	3,790,000	(6,727,000)	3,622,000
Changes in operating assets and liabilities:
Accounts receivable		(673,000)	(1,313,000)
Prepaid expenses and other assets		(4,228,000)	219,000
Accounts payable		62,000	(1,229,000)
Accrued expenses and other liabilities		(1,854,000)	1,288,000
Accrued compensation and benefits		(1,926,000)	(7,514,000)
Operating lease liabilities		(1,046,000)	(2,081,000)
Other		(10,000)	0
Net cash used in operating activities		(26,806,000)	(31,337,000)
Cash flows from investing activities:
Receipts of term deposit maturities		6,559,000	0
Purchases of property and equipment		(667,000)	(99,000)
Purchases of term deposits		0	(2,665,000)
Net cash provided by (used in) investing activities		5,892,000	(2,764,000)
Cash flows from financing activities:
Proceeds from exercise of options		461,000	330,000
Taxes withheld and paid related to net share settlement of equity awards		(3,437,000)	(557,000)
Net cash used in financing activities		(2,976,000)	(227,000)
Effect of changes in currency exchange rates on cash and cash equivalents		(331,000)	175,000
Net decrease in cash and cash equivalents		(24,221,000)	(34,153,000)
Cash, cash equivalents and restricted cash, beginning of the period		145,785,000	194,965,000
Cash, cash equivalents and restricted cash, end of the period	160,812,000	121,564,000	160,812,000
Reconciliation of cash, cash equivalents and restricted cash to the amounts reported within the consolidated balance sheets
Cash and cash equivalents	159,526,000	120,475,000	159,526,000
Restricted cash	1,286,000	1,089,000	1,286,000
Total cash, cash equivalents and restricted cash, end of the period	160,812,000	121,564,000	160,812,000
Supplemental disclosure of non-cash investing and financing activities:
Lease liabilities arising from obtaining right-of-use assets		4,506,000	0
Vesting of early exercised stock options and restricted stock awards	$ 67,000	71,000	198,000
Property and equipment purchases not yet paid		13,000	0
Issuance of common stock upon release of restricted stock units		$ 1,000	$ 0